(M7U) Nynomic - Overview
Sector: Technology | Industry: Scientific & Technical Instruments | Exchange: XETRA (Germany) | Market Cap: 149m EUR | Total Return: 63.6% in 12m
Avg Turnover: 1.08M
Rev. Trend: -78.1%
Warnings
Below Avwap Earnings
Tailwinds
Rs Leader, Idiosyncratic Leader
Nynomic AG specializes in the development and production of optical measurement technology for non-destructive testing and permanent monitoring. The company operates across the entire value chain, providing components such as light sources and fiber optics, as well as integrated systems for industrial spectroscopy and laboratory automation. Its technology portfolio includes UV-VIS-NIR and Raman diode array spectroscopy, serving sectors ranging from digital plant phenotyping to industrial process control.
The business model relies on high levels of integration, where optical sensors are embedded directly into customer production lines to enable real-time quality control. This approach is characteristic of the photonics industry, which often benefits from high switching costs once a specific optical solution is integrated into a clients manufacturing workflow. As a micro-cap entity in the electronic equipment sector, Nynomic focuses on niche OEM applications and scientific markets that require high-precision calibration and specialized infrared measurement technology.
For a detailed breakdown of the companys financial health and valuation metrics, consider reviewing the latest data on ValueRay. Nynomic AG, headquartered in Wedel, Germany, has expanded its reach through multiple subsidiaries since its founding in 1995 and its subsequent rebranding from m-u-t AG in 2018.
- Organic revenue growth driven by industrial automation and laboratory spectroscopy demand
- Strategic acquisitions expand product portfolio and addressable optical sensor markets
- Margin expansion through increased share of high-margin proprietary software solutions
- Exposure to cyclical capital expenditure trends within European semiconductor and agricultural sectors
| Net Income: -1.38m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 2.54 > 1.0 |
| NWC/Revenue: 30.01% < 20% (prev 30.67%; Δ -0.66% < -1%) |
| CFO/TA 0.09 > 3% & CFO 11.8m > Net Income -1.38m |
| Net Debt (16.3m) to EBITDA (11.4m): 1.43 < 3 |
| Current Ratio: 2.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.24m) vs 12m ago 0.0% < -2% |
| Gross Margin: 28.66% > 18% (prev 0.27%; Δ 2.84k% > 0.5%) |
| Asset Turnover: 97.74% > 50% (prev 105.2%; Δ -7.44% > 0%) |
| Interest Coverage Ratio: 2.79 > 6 (EBITDA TTM 11.4m / Interest Expense TTM 1.31m) |
| A: 0.30 (Total Current Assets 61.5m - Total Current Liabilities 21.4m) / Total Assets 133.8m |
| B: 0.37 (Retained Earnings 49.4m / Total Assets 133.8m) |
| C: 0.03 (EBIT TTM 3.66m / Avg Total Assets 136.7m) |
| D: 1.68 (Book Value of Equity 55.7m / Total Liabilities 33.2m) |
| Altman-Z'' = 5.11 = AAA |
| DSRI: 1.08 (Receivables 18.0m/18.4m, Revenue 133.6m/146.8m) |
| GMI: 0.94 (GM 28.66% / 27.01%) |
| AQI: 1.04 (AQ_t 0.38 / AQ_t-1 0.37) |
| SGI: 0.91 (Revenue 133.6m / 146.8m) |
| TATA: -0.10 (NI -1.38m - CFO 11.8m) / TA 133.8m) |
| Beneish M = -3.15 (Cap -4..+1) = AA |
As of May 31, 2026, the stock is trading at EUR 20.70 with a total of 30,695 shares traded.
Over the past week, the price has changed by +7.25%,
over one month by +1.47%,
over three months by +109.09% and
over the past year by +63.64%.
Nynomic has no consensus analysts rating.
P/E Forward = 34.4828
P/S = 1.5259
P/B = 1.4651
Revenue TTM = 133.6m EUR
EBIT TTM = 3.66m EUR
EBITDA TTM = 11.4m EUR
Long Term Debt = unknown (none)
Short Term Debt = 6.19m EUR (from shortTermDebt, last fiscal year)
Debt = 30.8m EUR (from shortLongTermDebtTotal, last fiscal year) + Leases 12.9m
Net Debt = 16.3m EUR (calculated: Debt 30.8m - CCE 14.5m)
Enterprise Value = 165.4m EUR (149.1m + Debt 30.8m - CCE 14.5m)
Interest Coverage Ratio = 2.79 (Ebit TTM 3.66m / Interest Expense TTM 1.31m)
EV/FCF = 17.40x (Enterprise Value 165.4m / FCF TTM 9.51m)
FCF Yield = 5.75% (FCF TTM 9.51m / Enterprise Value 165.4m)
FCF Margin = 7.12% (FCF TTM 9.51m / Revenue TTM 133.6m)
Net Margin = -1.03% (Net Income TTM -1.38m / Revenue TTM 133.6m)
Gross Margin = 28.66% ((Revenue TTM 133.6m - Cost of Revenue TTM 95.3m) / Revenue TTM)
Gross Margin QoQ = 54.20% (prev 16.44%)
Tobins Q-Ratio = 1.24 (Enterprise Value 165.4m / Total Assets 133.8m)
Interest Expense / Debt = 4.25% (Interest Expense 1.31m / Debt 30.8m)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 2.74m (EBIT 3.66m * (1 - 25.00%))
Current Ratio = 2.87 (Total Current Assets 61.5m / Total Current Liabilities 21.4m)
Debt / Equity = 0.32 (Debt 30.8m / totalStockholderEquity, last fiscal year 96.3m)
Debt / EBITDA = 1.43 (Net Debt 16.3m / EBITDA 11.4m)
Debt / FCF = 1.72 (Net Debt 16.3m / FCF TTM 9.51m)
Total Stockholder Equity = 97.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.01% (Net Income -1.38m / Total Assets 133.8m)
RoE = -1.42% (Net Income TTM -1.38m / Total Stockholder Equity 97.4m)
RoCE = 3.25% (EBIT 3.66m / Capital Employed (Total Assets 133.8m - Current Liab 21.4m))
RoIC = 2.63% (NOPAT 2.74m / Invested Capital 104.1m)
WACC = 7.72% (E(149.1m)/V(179.9m) * Re(8.66%) + D(30.8m)/V(179.9m) * Rd(4.25%) * (1-Tc(0.25)))
Discount Rate = 8.66% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -24.18 | Cagr: -18.54%
[DCF] Terminal Value 77.97% ; FCFF base≈8.25m ; Y1≈9.46m ; Y5≈13.9m
[DCF] Fair Price = 29.40 (EV 209.4m - Net Debt 16.3m = Equity 193.1m / Shares 6.57m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
Revenue Correlation: -78.08 | Revenue CAGR: -10.22% | SUE: N/A | # QB: 0